• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Packaging Technology

    Elemental Impurities: The Time Has Come

    Continuous vs. Batch Production

    2018: The evolution of pharmaceutical packaging

    Formulation Development Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Thermo Fisher Invests $50M to Grow Biologics Footprint

    Q Therapeutics, REPROCELL Form MAGiQ Therapeutics

    Synpromics, Lonza Enter Partnership

    Noramco, SPI Pharma Sign Agreement

    Codexis, Porton Enter Collaboration
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Thermo Fisher Invests $50M to Grow Biologics Footprint

    Codexis, Porton Enter Collaboration

    WuXi AppTec Opens Laboratory Testing Facility in NJ

    Arcinova Receives £1.5M Innovate UK Grant

    Vetter Welcomes Illinois Governor
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    INTERPHEX: Adents Showcases Cloud-Based Serialization Solution

    Almac Group Expands Packaging Capabilities

    Catalent Bolsters Clinical Supply Capabilities

    West, Stevanato Group Enter Ompi EZ-fill Alliance

    Pharmaceutical Packaging Technology
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Q Therapeutics, REPROCELL Form MAGiQ Therapeutics

    Noramco, SPI Pharma Sign Agreement

    Codexis, Porton Enter Collaboration

    AMRI Expands NMR Spec Capabilities in Europe

    WuXi AppTec Opens Laboratory Testing Facility in NJ
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Blockchain: The Next Big Trend in BioPharma?

    Emergent Completes Market Authorization

    Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle: ICH Q12

    LSNE Expands Capabilities and QC Laboratory Space

    Evotec Launches Drug Development Service
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Unither Pharmaceuticals

    Alcami

    Exelead

    Rockledge Pharmaceutical Manufacturing, LLC

    Avista Pharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Bavarian Nordic Partners With U.S. DoD

    Collaboration valued up to $36M for multivalent vaccine to fight equine encephalitis virus

    Related CONTENT
    • Contracting & Outsourcing Session Highlights and Key Takeaways
    • Bavarian Nordic Gets $539M BARDA Contract for Smallpox Vaccine
    • Sterile Manufacturing Future Trends and Challenges
    • SGS and Bavarian Nordic Form Vaccine Collaboration
    • Financial Report: Emergent BioSolutions
    03.16.18
    Bavarian Nordic A/S has signed a new alliance with the U.S. Department of Defense (DoD) for the development of a prophylactic vaccine against the equine encephalitis virus-a rare, but potentially deadly mosquito-borne illness. With funding from the DoD, Bavarian Nordic will use its proprietary MVA-BN platform to develop a vaccine against various strains of the virus, for which there is currently no preventative vaccine treatment available.

    An MVA-BN-based candidate vaccine targeting three separate equine encephalitis viruses including Eastern (EEEV), Venezuelan (VEEV), and Western (WEEV) has already demonstrated efficacy against all three viruses in preclinical models. The multi-year collaboration will include further preclinical studies to support clinical development, GMP production and establishment of safety and immunogenicity in humans. Clinical proof of concept data will warrant further development of the MVA-BN-based candidate vaccine with potential follow-on funding towards FDA licensure and production. The vaccine would then be available to the DoD as needed to vaccinate individuals who may be deployed in a region considered at high risk for a particular illness.

    The agreement includes total potential considerations of approximately $36 million.

    "We are very proud of this alliance which represents yet another public/private engagement between Bavarian Nordic and the U.S. government, and provides the Department of Defense with the first in what could become a 'library' of safe, clinically validated vaccines that are readily accessible and can be deployed as needed," said Paul Chaplin, president and chief executive officer, Bavarian Nordic. "This type of collaboration further validates our model for preparedness, which could prove useful in the years to come for this, and potentially other rare and tropical diseases."
    Related Searches
    • fda
    • production
    • vaccines
    • clinical development
    Suggested For You
    Drug Safety Update Drug Safety Update
    Bavarian Nordic, AstraZeneca, & Georgetown Team Up Bavarian Nordic, AstraZeneca, & Georgetown Team Up
    Pii Receives 7 Market Approvals from FDA in 2017 Pii Receives 7 Market Approvals from FDA in 2017
    Phillips-Medisize to Expand Little Rock Facility Phillips-Medisize to Expand Little Rock Facility
    PixarBio, Particle Sciences Enter Manufacturing Agreement PixarBio, Particle Sciences Enter Manufacturing Agreement
    Melinta Buys Infectious Disease Unit from The Medicines Company Melinta Buys Infectious Disease Unit from The Medicines Company
    Flexible Manufacturing Strategies and Data Integrity Flexible Manufacturing Strategies and Data Integrity
    U.S. DoD Awards Grant to SiteOne Therapeutics U.S. DoD Awards Grant to SiteOne Therapeutics
    Financial Report: Emergent BioSolutions Financial Report: Emergent BioSolutions
    SGS and Bavarian Nordic Form Vaccine Collaboration SGS and Bavarian Nordic Form Vaccine Collaboration
    Sterile Manufacturing Future Trends and Challenges Sterile Manufacturing Future Trends and Challenges
    Bavarian Nordic Gets $539M BARDA Contract for Smallpox Vaccine Bavarian Nordic Gets $539M BARDA Contract for Smallpox Vaccine
    Contracting & Outsourcing Session Highlights and Key Takeaways Contracting & Outsourcing Session Highlights and Key Takeaways

    Related Breaking News

    • Bio News | Breaking News | Facilities | Industry News
      GE Opens

      GE Opens 'Factory-in-a-Box' for Viral Vector Production

      New factory-in-a-box accelerates the production of viral vector-based therapeutics
      04.17.18

    • Bio News | Breaking News | Industry News
      Wacker Buys Dutch Biotechnology Plant

      Wacker Buys Dutch Biotechnology Plant

      Takes over Synco Bio of Amsterdam; strengthens pharmaceutical protein business
      04.17.18

    • Bio News | Breaking News | Facilities | Industry News
      Lonza Opens Cell and Gene Therapy Mfg. Facility

      Lonza Opens Cell and Gene Therapy Mfg. Facility

      Houston site will produce treatments for rare genetic disorders and life-threatening diseases
      04.10.18


    • Bio News | Breaking News | Collaborations & Alliances | Industry News
      ReForm Biologics, KBI Sign Strategic Agreement

      ReForm Biologics, KBI Sign Strategic Agreement

      To make advanced biopharmaceutical formulations with the goal of enhancing manufacturing efficiencies
      04.04.18

    • Bio News | Breaking News | Industry News
      Therapure Biopharma Launches Biologics Division

      Therapure Biopharma Launches Biologics Division

      New plasma products and technology company-Evolve Biologics-led by Blaine Forshage as CEO
      04.03.18

    • cGMP Manufacture | Industry News
      AGC Biologics Expands U.S. Footprint

      AGC Biologics Expands U.S. Footprint

      New 150,000 sq.-ft. complex will house the company's process development labs and corporate administrative offices
      04.02.18


    • Bio News | Breaking News | Industry News
      Gyros Protein Technologies Upgrades Services

      Gyros Protein Technologies Upgrades Services

      Installs two Gyrolab xPlore systems at Oxford BioMedica for gene and cell therapy applications
      03.29.18

    • Industry News | Reader Showcase
      SSCI Implements New Instruments

      SSCI Implements New Instruments

      Mettler Toledo’s thermal analysis instruments meet the updated regulatory data integrity standards
      03.29.18

    • Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
      Abzena Expands ADC Capabilities

      Abzena Expands ADC Capabilities

      Facility remodeling completed for new ADC GMP manufacturing suite
      03.27.18


    • Bio News | Collaborations & Alliances | Industry News
      Shire & NanoMedSyn Enter Collaboration

      Shire & NanoMedSyn Enter Collaboration

      To evaluate a potential ERT using NanoMedSyn's proprietary synthetic derivatives named AMFA
      03.26.18

    • Bio News | Breaking News | cGMP Manufacture | Facilities | Industry News
      Aldevron Begins Construction of Cleanrooms in $30M GMP Plasmid Facility

      Aldevron Begins Construction of Cleanrooms in $30M GMP Plasmid Facility

      AES Clean Technology to design modular cleanrooms for the $30 million, 70,000 sq. ft. manufacturing facility
      03.23.18

    • Breaking News | Collaborations & Alliances | Industry News
      Innate Biologics Enters Collaboration With The Wistar Institute

      Innate Biologics Enters Collaboration With The Wistar Institute

      Collaboration focused on new approaches to target and treat inflammation at the molecular level
      03.23.18

    • Bio News | Collaborations & Alliances | CRO News | Industry News
      Tergus Pharma Acquires EnDev Laboratories

      Tergus Pharma Acquires EnDev Laboratories

      To add extensive early-phase drug development capabilities from lead compound selection to skin biology
      03.23.18

    • Bio News | Breaking News | Industry News
      Covance Launches Immunology & Immunotoxicology Unit

      Covance Launches Immunology & Immunotoxicology Unit

      The new team will be dedicated to the specific needs of biologic drug development
      03.22.18

    • Bio News | Industry News | Promotions & Moves
      Nabriva Therapeutics Appoints CMO

      Nabriva Therapeutics Appoints CMO

      Dr. Jennifer Schranz joins the company with over two decades of pharmaceutical industry experience
      03.21.18

    Breaking News
    • Thermo Fisher Invests $50M to Grow Biologics Footprint
    • Q Therapeutics, REPROCELL Form MAGiQ Therapeutics
    • Synpromics, Lonza Enter Partnership
    • Noramco, SPI Pharma Sign Agreement
    • Codexis, Porton Enter Collaboration
    View Breaking News >
    CURRENT ISSUE

    April 2018

    • Pharmaceutical Packaging Technology
    • Elemental Impurities: The Time Has Come
    • Continuous vs. Batch Production
    • 2018: The evolution of pharmaceutical packaging
    • Formulation Development Trends
    • Changing Dynamics: The CDMO market in focus
    • Contract BioManufacturing in China: Creating a New Segment
    • View More >

    Copyright © 2018 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.